{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T08:47:30Z","timestamp":1768121250637,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["CZ.02.1.01-0.0-0.0-17 048- 0007441"],"award-info":[{"award-number":["CZ.02.1.01-0.0-0.0-17 048- 0007441"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["FN HK 00179906"],"award-info":[{"award-number":["FN HK 00179906"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.msard.2021.103104","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T08:55:04Z","timestamp":1624524904000},"page":"103104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia"],"prefix":"10.1016","volume":"54","author":[{"given":"Dominika","family":"Stastna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Menkyova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Drahota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Mazouchova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Adamkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Ampapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Grunermelova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Peterka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Recmanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Rockova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matous","family":"Rous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Stetkarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Valis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Vachova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Woznicova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Horakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103104_bib0001","article-title":"COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America","volume":"51","author":"Alonso","year":"2021","journal-title":"Mult. Scler. Rel. Disord."},{"key":"10.1016\/j.msard.2021.103104_bib0002","unstructured":"\u010cesk\u00fd statistick\u00fd \u00fa\u0159ad, n.d.Obyvatelstvo | \u010cS\u00da [WWW Document]. URL https:\/\/www.czso.cz\/csu\/czso\/obyvatelstvo_lide (accessed 4.17.21)."},{"key":"10.1016\/j.msard.2021.103104_bib0003","series-title":"COVID-19 in MS and NMOSD: A multicentric online national survey in Chile","author":"Ciampi","year":"2020"},{"key":"10.1016\/j.msard.2021.103104_bib0004","article-title":"Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"44","author":"Creed","year":"2020","journal-title":"Mult. Scler. Rel. Disord."},{"key":"10.1016\/j.msard.2021.103104_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1212\/NXI.0000000000000787","article-title":"Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders","volume":"7","author":"Fan","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2021.103104_bib0006","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/thoraxjnl-2020-215314","article-title":"Respiratory follow-up of patients with COVID-19 pneumonia","volume":"75","author":"George","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.msard.2021.103104_bib0007","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2021.103104_bib0008","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11079","article-title":"Covid 19 in Northern Italy: an integrative overview of factors possibly influencing the sharp increase of the outbreak (Review)","author":"Goumenou","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.msard.2021.103104_bib0009","series-title":"COVID 19: P\u0159ehled aktu\u00e1ln\u00ed situace v \u010cR [WWW Document]. Onemocn\u011bn\u00ed aktu\u00e1ln\u011b [online]","author":"Komenda","year":"2021"},{"key":"10.1016\/j.msard.2021.103104_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.2581","article-title":"Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis","volume":"77","author":"Louapre","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2021.103104_bib0011","article-title":"Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders","volume":"14612","author":"Louapre","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2021.103104_bib0012","series-title":"Multiple sclerosis and COVID-19 164","first-page":"217","author":"Mares","year":"2020"},{"key":"10.1016\/j.msard.2021.103104_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30270-8","article-title":"B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.msard.2021.103104_bib0014","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3390\/jcm9124067","article-title":"Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases","volume":"9","author":"M\u00f6hn","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2021.103104_bib0015","unstructured":"NF IMPULS [WWW Document], URLhttp:\/\/www.multiplesclerosis.cz\/. (accessed 4.18.21)."},{"key":"10.1016\/j.msard.2021.103104_bib0016","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458520941485","article-title":"COVID-19 in people with multiple sclerosis: a global data sharing initiative","volume":"26","author":"Peeters","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103104_bib0017","article-title":"Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran","author":"Sahraian","year":"2020","journal-title":"Mult. Scler. Rel. Disord."},{"key":"10.1016\/j.msard.2021.103104_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.0688","article-title":"Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis","author":"Salter","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2021.103104_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102800","article-title":"COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: a systematic review","author":"Sharifian-Dorche","year":"2021","journal-title":"Mult. Scler. Rel. Disord."},{"key":"10.1016\/j.msard.2021.103104_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26028","article-title":"Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis","volume":"89","author":"Sormani","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.103104_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-018-0568-7","article-title":"Ocrelizumab: a review in multiple sclerosis","author":"Syed","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2021.103104_bib0022","series-title":"Clinical Management of COVID-19","year":"2020"},{"key":"10.1016\/j.msard.2021.103104_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520949152","article-title":"MS, pregnancy and COVID-19","author":"Yam","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103104_bib0024","article-title":"COVID-19 infection in NMO\/SD patients: a French survey","author":"Zeidan","year":"2020","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:00:22Z","timestamp":1761901222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S2211034821003710"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103104","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103104"}}